This inventor holds 2 USPTO granted patents. Top assignee: The UAB Research Foundation (The University of Alabama at Birmingham). Active years: 1999-2001.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Vancouver, CA (1999)
- Burnaby, CA (2001)
Company Filing History:
Years Active: 1999-2001
Title: Guojun Zhao: Innovator in Multiple Sclerosis Research
Introduction
Guojun Zhao is a notable inventor based in Burnaby, Canada. He has made significant contributions to the field of medical research, particularly in understanding multiple sclerosis. With a total of 2 patents, his work focuses on innovative methods for diagnosing and monitoring this complex disease.
Latest Patents
Zhao's latest patents include groundbreaking methods related to multiple sclerosis. One patent describes a method for determining the status of a multiple sclerosis patient by measuring urinary p-cresol sulfate. This method can predict the transition from a relapsing-remitting phase to a progressive phase of the disease. Additionally, it provides a way to assess the amount of lesions and total lesion area in patients. Another patent outlines a method for measuring urinary myelin basic protein-like material, which serves a similar purpose in monitoring the disease's progression and myelination in developing children.
Career Highlights
Guojun Zhao is affiliated with the UAB Research Foundation, where he continues to advance his research in multiple sclerosis. His work is characterized by a commitment to improving patient outcomes through innovative diagnostic methods. Zhao's contributions have the potential to change how multiple sclerosis is monitored and treated.
Collaborations
Zhao has collaborated with notable colleagues, including John Nicholas Whitaker and Robert David Kachelhofer. These partnerships have enriched his research and expanded the impact of his inventions.
Conclusion
Guojun Zhao's innovative work in multiple sclerosis research exemplifies the importance of scientific inquiry in improving healthcare. His patents reflect a dedication to enhancing diagnostic methods, ultimately benefiting patients and the medical community.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
